All Resources

Cell Therapy Development

Datasheet: The Opto™ Antigen Presenting Bead Kit

Learn more about the Opto™ Antigen Presenting Bead (Opto™ APB) Kit, its key applications, and how it benefits your cell therapy development workflows by efficiently expanding more antigen-specific T cells than dendritic cells.

Antibody Discovery

Brochure: Antibody Discovery

Find out how Opto™ Plasma B Discovery using the Beacon® optofluidic system accelerates lead molecule discovery against difficult targets.

Antibody Discovery

Product Tour: The Opto™ Plasma B Discovery 4.0 Workflow

Antibody expert, Anupam Singhal, PhD, does a 10-minute walkthrough of how the Opto™ Plasma B Discover workflow makes it possible to accelerate lead molecule discovery against difficult targets.

Antibody Discovery

Webinar: A Beacon for Rapid Antibody Discovery against Difficult Targets

Panelists from Genovac, will present case studies of how they have leveraged their core genetic immunization technology and the Beacon optofluidic system to rapidly discover antibodies against challenging targets, such as GPCRs, from a variety of different animal species.

Cell Therapy Development

Application Note: Unravel the Complexity of Single Natural Killer Cell Cytotoxicity and ADCC Mediation

Explore how the Cytotoxicity Assay can be used to characterize and better understand NK cells in the pursuit of more efficacious cell therapies.

Cell Therapy Development

Poster: Antigen Validation using Berkeley Lights Opto™ Antigen Presenting Bead Kit

Explore the data from the Opto Antigen Presenting Bead Kit and its ability to relieve a critical bottleneck in the tumor antigen discovery process.

Antibody Discovery

Application Note: Rapid High-Resolution Screening of Plasma B Cells to Identify Antibody Lead Candidates

Explore case studies for the rapid discovery of antibodies against challenging targets.

Antibody Discovery

Customer Spotlight: Abveris on Antibody Discovery

Find out how Abveris is transforming their antibody discovery processes with the Beacon® optofluidic system.

Beacon System Lightning System

Datasheet: Cell Analysis Suite (CAS™) 2.1 Software

Review our premier software, its key applications, and the features exclusive to the 2.1 upgrade.

Cell Therapy Development

Application Note: Multidimensional Analysis of T Cell Cytotoxicity and Serial Killing Using the Opto™ Cell Therapy Development Workflow

Learn how to use multiple assays on single T cells to finally understand critical functions, such as serial killing, and how they relate to each other.

Cell Therapy Development

Application Note: Identify and Select Optimal CAR T Cell Phenotypes with the Opto™ Cell Therapy Development Workflow

Learn how to combine the T Cell Proliferation Assay with either the Multiplex Cytokine Assay or Cytotoxicity Assay to find your most persistent T cells.

Antibody Discovery Cell Line Development

Customer Spotlight: Amgen on AbD and CLD

Find out how Amgen is transforming their antibody discovery and clonal cell line processes with the Berkeley Lights Platform.

Cell Therapy Development

Webinar: Expand and Rapidly Validate Antigen-Specific Function of T Cells Using Fewer Cells

Yelena Bronevetsky, PhD, lays out the current challenges in tumor antigen discovery and how our Opto™ Antigen Presenting Bead Kit helps scientists overcome them.

Cell Line Development

Fireside Chat: Every Day Matters – Optimizing COVID-19 Therapies for Manufacturing

Dr. James Rothman, Nobel Laureate hosts an in-depth discussion with distinguished guests, Dr. Jennitte Stevens from Amgen, Dr. Gregory Bleck from Catalent-Biologics, and Dr. Trent Munro from the University of Queensland on fast-tracking the development of therapeutic antibodies and vaccines for SARS-CoV-2.

Cell Line Development

Customer Spotlight: Catalent on CLD

Find out how Catalent Biologics is able to select significantly higher expressing clonal cell lines with the Opto CLD workflow.

Cell Therapy Development

Product Tour: The Opto™ Cell Therapy Development Workflow

Guided by T cell expert, Yelena Bronevetsky, PhD, get a deeper look at how the Opto™ Cell Therapy Development workflow can be used to validate, expand, and fully characterize over a 1,000 T cells.

Antibody Discovery

Application Note: Rapid Discovery of Therapeutic Antibodies for the SARS-CoV-2 Pandemic Virus Using the Opto Viral Neutralization 1.0 Workflow

Learn how to use blocking and binding assays and the Opto Viral Neutralization 1.0 workflow to identify cross-reactive antibodies that may have broad neutralization capacity across the coronavirus family.

Cell Line Development

Product Tour: The Opto™ CLD Workflow

Antibody expert, Anupam Singhal, PhD, does a 10-minute walkthrough of how the Opto™ CLD workflow makes it possible to produce superior cell lines, with >99% monoclonality assurance, in a matter of days.